Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Miriam Post

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stillbirth
2
2024
57
1.740
Why?
Placenta
9
2024
628
1.600
Why?
Ovarian Neoplasms
12
2023
386
1.280
Why?
Uterine Neoplasms
6
2019
73
1.270
Why?
Carcinosarcoma
5
2018
17
1.160
Why?
Clinical Competence
3
2022
882
0.890
Why?
Fetal Death
1
2023
50
0.880
Why?
Pathologists
3
2017
13
0.790
Why?
Endometrial Neoplasms
6
2023
141
0.780
Why?
Education, Medical, Continuing
1
2022
115
0.740
Why?
Cystadenocarcinoma, Serous
4
2022
43
0.640
Why?
Microfilament Proteins
1
2017
125
0.550
Why?
Hemangioma, Capillary
1
2015
13
0.480
Why?
Autopsy
2
2024
83
0.440
Why?
Lymph Nodes
4
2018
415
0.440
Why?
Carrier Proteins
1
2017
694
0.440
Why?
Fetus
3
2024
698
0.430
Why?
Pre-Eclampsia
2
2021
166
0.430
Why?
Immunohistochemistry
8
2023
1624
0.390
Why?
Pathology
3
2017
20
0.380
Why?
Female
49
2024
59324
0.380
Why?
Pregnancy
10
2024
5499
0.370
Why?
Fetal Growth Retardation
2
2021
470
0.350
Why?
Biomarkers, Tumor
9
2023
1032
0.350
Why?
Adenocarcinoma, Mucinous
2
2022
61
0.340
Why?
Humans
56
2024
114045
0.330
Why?
Prognosis
10
2023
3315
0.330
Why?
Osteoblastoma
1
2008
2
0.320
Why?
Prolactinoma
1
2008
11
0.320
Why?
Skull Base
1
2008
39
0.310
Why?
Skull Base Neoplasms
1
2008
24
0.310
Why?
Neoplasms, Multiple Primary
1
2008
52
0.300
Why?
Cytomegalovirus
1
2009
143
0.300
Why?
Peritoneal Neoplasms
3
2014
54
0.290
Why?
Fetal Diseases
1
2009
146
0.290
Why?
Pituitary Neoplasms
1
2008
156
0.280
Why?
Lymphatic Vessels
2
2018
54
0.280
Why?
Uterus
3
2022
191
0.280
Why?
Professionalism
2
2017
14
0.280
Why?
Gestational Age
4
2024
761
0.280
Why?
Cytomegalovirus Infections
1
2009
180
0.270
Why?
Receptors, Estrogen
5
2017
371
0.260
Why?
Diagnosis, Differential
5
2019
1331
0.260
Why?
Infant, Newborn
4
2024
5038
0.250
Why?
Neoplasm Recurrence, Local
3
2022
850
0.250
Why?
Pregnancy Complications, Infectious
1
2009
285
0.240
Why?
Interleukin-6
2
2021
673
0.240
Why?
Education, Medical, Graduate
4
2017
366
0.230
Why?
Uterine Cervical Neoplasms
2
2021
213
0.230
Why?
Hypertension, Pulmonary
1
2015
1736
0.220
Why?
Internship and Residency
3
2017
920
0.220
Why?
Neoplasm Invasiveness
6
2018
438
0.220
Why?
Middle Aged
20
2023
26605
0.210
Why?
Lung Neoplasms
2
2015
2159
0.210
Why?
Neoplasm Staging
5
2019
1162
0.210
Why?
Endodermal Sinus Tumor
1
2022
7
0.210
Why?
Choriocarcinoma
1
2022
8
0.210
Why?
Tertiary Care Centers
1
2023
126
0.210
Why?
Fallopian Tubes
1
2022
29
0.210
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2023
68
0.210
Why?
Dendritic Cell Sarcoma, Follicular
1
2022
2
0.210
Why?
Carcinoma, Endometrioid
2
2022
46
0.210
Why?
In Situ Hybridization, Fluorescence
1
2023
308
0.200
Why?
Carcinoma, Squamous Cell
2
2021
577
0.200
Why?
Specialty Boards
1
2022
32
0.200
Why?
Antigens, CD
2
2015
440
0.190
Why?
Hysterectomy
3
2022
105
0.190
Why?
Neoplasms, Germ Cell and Embryonal
1
2022
62
0.190
Why?
Certification
1
2022
84
0.190
Why?
Cell Line, Tumor
10
2023
2700
0.190
Why?
Carcinoma, Adenosquamous
1
2021
9
0.190
Why?
Gene Expression Regulation, Neoplastic
3
2019
1145
0.190
Why?
beta Catenin
2
2023
218
0.190
Why?
Granulosa Cells
1
2021
29
0.190
Why?
Drug Resistance, Neoplasm
3
2023
636
0.190
Why?
Ovary
1
2022
190
0.190
Why?
Ovarian Follicle
1
2021
61
0.180
Why?
Programmed Cell Death 1 Receptor
1
2022
193
0.180
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
111
0.180
Why?
Decidua
2
2012
23
0.180
Why?
High-Throughput Nucleotide Sequencing
1
2023
437
0.180
Why?
Adult
20
2023
30375
0.170
Why?
Neovascularization, Physiologic
1
2021
174
0.170
Why?
Phthalazines
1
2019
38
0.160
Why?
Leiomyosarcoma
1
2019
26
0.160
Why?
Endometrium
2
2022
60
0.160
Why?
Estrogens
2
2012
312
0.160
Why?
Leiomyoma
1
2019
44
0.160
Why?
Histocompatibility Antigens
1
2019
98
0.160
Why?
Gene Expression Profiling
4
2019
1518
0.160
Why?
Antineoplastic Agents
2
2023
1875
0.160
Why?
Up-Regulation
1
2021
802
0.150
Why?
Histone-Lysine N-Methyltransferase
1
2019
96
0.150
Why?
Adenocarcinoma
2
2015
787
0.150
Why?
Diverticulum
1
2018
11
0.150
Why?
Uterine Diseases
1
2018
14
0.150
Why?
Premature Birth
1
2021
275
0.150
Why?
Adenocarcinoma, Clear Cell
1
2018
14
0.150
Why?
Fetal Blood
2
2021
268
0.150
Why?
Extracellular Matrix
1
2021
436
0.140
Why?
Piperazines
1
2019
310
0.140
Why?
Cytoreduction Surgical Procedures
1
2017
39
0.140
Why?
Retinopathy of Prematurity
1
2018
111
0.140
Why?
Blood Vessels
1
2018
179
0.140
Why?
Cisplatin
2
2015
262
0.130
Why?
Cell Proliferation
5
2015
2173
0.130
Why?
Employment
1
2017
137
0.130
Why?
Job Satisfaction
1
2017
168
0.130
Why?
Endothelial Cells
1
2021
677
0.130
Why?
Breast Neoplasms
3
2012
1846
0.130
Why?
Medroxyprogesterone Acetate
1
2015
28
0.130
Why?
Receptors, Progesterone
3
2015
319
0.130
Why?
Pelvic Neoplasms
1
2015
18
0.130
Why?
Mutation
2
2023
3338
0.130
Why?
Neoplasms, Glandular and Epithelial
1
2015
34
0.130
Why?
Keratin-5
1
2015
46
0.120
Why?
Oxidative Stress
1
2021
1068
0.120
Why?
Skin Neoplasms
2
2012
754
0.120
Why?
Lymphangioleiomyomatosis
1
2015
27
0.120
Why?
Tuberous Sclerosis
1
2015
36
0.120
Why?
Incidental Findings
1
2015
70
0.120
Why?
Antineoplastic Agents, Hormonal
1
2015
138
0.120
Why?
Educational Measurement
1
2016
235
0.120
Why?
Capillaries
1
2015
90
0.120
Why?
Xenograft Model Antitumor Assays
5
2019
695
0.120
Why?
Chest Pain
1
2015
82
0.120
Why?
Mesothelioma, Cystic
1
2014
1
0.120
Why?
Sarcoma
1
2016
137
0.120
Why?
Fetal Membranes, Premature Rupture
1
2014
34
0.120
Why?
Carcinoma
1
2016
198
0.120
Why?
Tumor Necrosis Factor-alpha
2
2021
1128
0.120
Why?
Chorioamnionitis
1
2014
36
0.110
Why?
Cough
1
2015
107
0.110
Why?
Lymphatic Metastasis
4
2018
275
0.110
Why?
Survival Rate
4
2018
1638
0.110
Why?
Glycoproteins
1
2015
304
0.110
Why?
Fertility Preservation
1
2014
46
0.110
Why?
Accreditation
1
2014
76
0.110
Why?
Adenomyosis
1
2013
1
0.110
Why?
Interleukin-8
1
2014
229
0.110
Why?
Dyspnea
1
2015
212
0.110
Why?
Robotics
1
2014
76
0.110
Why?
Fatigue
1
2015
294
0.110
Why?
Neural Stem Cells
1
2014
113
0.110
Why?
Gestational Trophoblastic Disease
1
2012
5
0.100
Why?
Menstrual Cycle
1
2013
108
0.100
Why?
Luteinizing Hormone
1
2013
169
0.100
Why?
Infertility
1
2013
45
0.100
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
25
0.100
Why?
Lectins
1
2012
42
0.100
Why?
Aged
11
2023
18969
0.100
Why?
Antigens, Differentiation, Myelomonocytic
1
2012
53
0.100
Why?
Carcinoma, Lobular
1
2012
44
0.100
Why?
Neoplastic Stem Cells
1
2015
327
0.100
Why?
Interleukin-1beta
1
2014
368
0.100
Why?
United States
4
2022
12137
0.100
Why?
Antibodies, Neoplasm
1
2012
30
0.100
Why?
Cicatrix
1
2012
49
0.100
Why?
Endometriosis
1
2012
40
0.100
Why?
Lymph Node Excision
3
2018
140
0.100
Why?
Apoptosis
4
2015
2349
0.100
Why?
Fallopian Tube Neoplasms
1
2011
14
0.100
Why?
Poly-ADP-Ribose Binding Proteins
2
2023
31
0.100
Why?
Paclitaxel
1
2012
190
0.090
Why?
DNA Polymerase II
2
2023
37
0.090
Why?
Nervous System Diseases
1
2014
254
0.090
Why?
Leptin
1
2012
210
0.090
Why?
Diagnostic Errors
1
2012
150
0.090
Why?
Bridged-Ring Compounds
1
2011
9
0.090
Why?
M Phase Cell Cycle Checkpoints
1
2011
23
0.090
Why?
Immunocompromised Host
1
2012
192
0.090
Why?
Trophoblastic Neoplasms
1
2010
2
0.090
Why?
Retrospective Studies
8
2018
12521
0.090
Why?
Carcinoma, Large Cell
1
2010
14
0.090
Why?
Neoplasms, Squamous Cell
1
2010
4
0.090
Why?
Skin Diseases
1
2012
121
0.090
Why?
Taxoids
1
2011
93
0.090
Why?
Cesarean Section
1
2012
169
0.090
Why?
B7-H1 Antigen
2
2022
137
0.090
Why?
Biological Evolution
1
2014
406
0.090
Why?
Carcinoma, Neuroendocrine
1
2010
29
0.090
Why?
Peptides
1
2015
847
0.090
Why?
Graft vs Host Disease
1
2012
212
0.090
Why?
Inflammation
2
2018
2464
0.090
Why?
Attitude of Health Personnel
1
2017
970
0.090
Why?
Genital Neoplasms, Female
1
2010
70
0.080
Why?
Biopsy
3
2022
1024
0.080
Why?
Africa, Eastern
1
2009
9
0.080
Why?
Amniocentesis
1
2009
21
0.080
Why?
Fever of Unknown Origin
1
2009
7
0.080
Why?
Neoplasm Grading
2
2019
241
0.080
Why?
Infarction
1
2008
12
0.080
Why?
Prolactin
1
2008
96
0.080
Why?
Homeodomain Proteins
1
2012
465
0.080
Why?
Blood Chemical Analysis
1
2008
90
0.080
Why?
Viremia
1
2009
122
0.070
Why?
Travel
1
2009
121
0.070
Why?
Models, Statistical
1
2011
595
0.070
Why?
Tumor Suppressor Protein p53
2
2023
445
0.070
Why?
Headache
1
2008
132
0.070
Why?
Surveys and Questionnaires
2
2017
4595
0.070
Why?
Neoplasm Proteins
1
2010
385
0.070
Why?
Immunoglobulin M
1
2009
245
0.070
Why?
Hematopoietic Stem Cell Transplantation
1
2012
519
0.070
Why?
Ultrasonography, Prenatal
1
2009
237
0.070
Why?
Case-Control Studies
3
2021
3003
0.070
Why?
Mice
7
2021
14843
0.070
Why?
Radiotherapy, Adjuvant
2
2018
182
0.070
Why?
MicroRNAs
1
2012
600
0.070
Why?
Disease Progression
3
2019
2371
0.070
Why?
Chemotherapy, Adjuvant
2
2018
332
0.060
Why?
Survival Analysis
2
2021
1206
0.060
Why?
Mice, Nude
3
2012
628
0.060
Why?
Animals
9
2021
31565
0.060
Why?
Follow-Up Studies
3
2018
4392
0.060
Why?
Prospective Studies
3
2023
6195
0.060
Why?
Immunoglobulin G
1
2009
766
0.060
Why?
DNA Mismatch Repair
1
2023
37
0.050
Why?
Activating Transcription Factor 6
1
2023
16
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1356
0.050
Why?
Brain
1
2014
2355
0.050
Why?
Transcription Factor AP-1
1
2023
81
0.050
Why?
Lung
1
2015
3521
0.050
Why?
Ultrasonography
2
2018
635
0.050
Why?
Magnetic Resonance Imaging
2
2013
3039
0.050
Why?
Eukaryotic Initiation Factor-2
1
2021
24
0.050
Why?
Mice, SCID
2
2012
312
0.050
Why?
Maternal Age
1
2021
116
0.050
Why?
Cervix Uteri
1
2021
44
0.050
Why?
Carcinogenesis
1
2022
175
0.050
Why?
Young Adult
4
2021
10444
0.050
Why?
Open Reading Frames
1
2021
117
0.050
Why?
Ligands
1
2022
556
0.050
Why?
Cellular Microenvironment
1
2021
77
0.040
Why?
Estradiol
2
2013
450
0.040
Why?
Cell Division
1
2021
754
0.040
Why?
Chitinase-3-Like Protein 1
1
2019
17
0.040
Why?
Tomography, X-Ray Computed
1
2008
2272
0.040
Why?
Protein Biosynthesis
1
2021
386
0.040
Why?
Intramolecular Oxidoreductases
1
2019
57
0.040
Why?
Microsatellite Instability
1
2019
32
0.040
Why?
Predictive Value of Tests
2
2015
1791
0.040
Why?
Protein Processing, Post-Translational
1
2021
399
0.040
Why?
Fetal Development
1
2021
248
0.040
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
76
0.040
Why?
Cytoskeletal Proteins
1
2019
145
0.040
Why?
Pregnancy, Tubal
1
2018
5
0.040
Why?
Ovarian Cysts
1
2018
8
0.040
Why?
Immunity, Maternally-Acquired
1
2018
18
0.040
Why?
Salpingectomy
1
2018
13
0.040
Why?
Microtubule-Associated Proteins
1
2019
171
0.040
Why?
Pelvic Pain
1
2018
32
0.040
Why?
PTEN Phosphohydrolase
1
2019
140
0.040
Why?
Frozen Sections
1
2018
24
0.040
Why?
Aged, 80 and over
2
2023
6306
0.040
Why?
Risk Factors
3
2018
8614
0.040
Why?
Abortion, Spontaneous
1
2018
89
0.040
Why?
Sequence Analysis, RNA
1
2019
388
0.040
Why?
Phosphorylation
1
2021
1558
0.030
Why?
Cell Movement
1
2021
863
0.030
Why?
Abortion, Induced
1
2018
71
0.030
Why?
Cohort Studies
2
2018
4883
0.030
Why?
Mass Spectrometry
1
2019
622
0.030
Why?
RNA-Binding Proteins
1
2019
344
0.030
Why?
Ifosfamide
1
2016
32
0.030
Why?
Faculty
1
2017
126
0.030
Why?
AC133 Antigen
1
2015
19
0.030
Why?
Transcriptome
1
2021
723
0.030
Why?
Cell Line
1
2021
2629
0.030
Why?
Tissue Array Analysis
1
2015
48
0.030
Why?
Cell Cycle Proteins
1
2019
549
0.030
Why?
Risk
1
2018
810
0.030
Why?
T-Lymphocytes
1
2022
1735
0.030
Why?
Cell Count
1
2015
303
0.030
Why?
Histones
1
2019
529
0.030
Why?
Sensitivity and Specificity
1
2019
1690
0.030
Why?
Fellowships and Scholarships
1
2017
224
0.030
Why?
Male
4
2017
55396
0.030
Why?
Receptors, Androgen
1
2015
131
0.030
Why?
Peritoneal Cavity
1
2014
23
0.030
Why?
Disease-Free Survival
1
2016
618
0.030
Why?
Laparoscopy
1
2018
395
0.030
Why?
RNA, Messenger
2
2012
2550
0.030
Why?
Pilot Projects
1
2018
1360
0.030
Why?
Follicular Phase
1
2013
36
0.030
Why?
Luteal Phase
1
2013
41
0.030
Why?
Hysteroscopy
1
2013
9
0.030
Why?
Primates
1
2014
110
0.030
Why?
Organ Size
1
2014
434
0.030
Why?
Oocytes
1
2014
169
0.030
Why?
Cryopreservation
1
2014
92
0.030
Why?
Membrane Proteins
1
2019
1016
0.030
Why?
Vaginal Neoplasms
1
2012
11
0.030
Why?
Karyotyping
1
2012
100
0.030
Why?
Anoikis
1
2012
31
0.030
Why?
Mothers
1
2018
650
0.030
Why?
Cell Survival
1
2015
1014
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2014
787
0.020
Why?
Transduction, Genetic
1
2012
113
0.020
Why?
Tamoxifen
1
2012
190
0.020
Why?
Protein Structure, Tertiary
1
2014
796
0.020
Why?
Perioperative Period
1
2011
47
0.020
Why?
Antibody Specificity
1
2012
175
0.020
Why?
Tumor Burden
1
2012
258
0.020
Why?
Gynecologic Surgical Procedures
1
2011
44
0.020
Why?
Tubulin
1
2012
122
0.020
Why?
Transplantation, Heterologous
1
2012
180
0.020
Why?
Biomarkers
1
2021
3397
0.020
Why?
Cell Adhesion
1
2012
426
0.020
Why?
Mice, Inbred NOD
1
2012
552
0.020
Why?
Selective Estrogen Receptor Modulators
1
2010
26
0.020
Why?
Adolescent
1
2008
17800
0.020
Why?
Cell Cycle Checkpoints
1
2011
84
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2010
57
0.020
Why?
Transfection
1
2012
863
0.020
Why?
Immunoenzyme Techniques
1
2010
192
0.020
Why?
Mitosis
1
2011
164
0.020
Why?
Organ Specificity
1
2010
266
0.020
Why?
HeLa Cells
1
2011
563
0.020
Why?
Regression Analysis
1
2011
945
0.020
Why?
Microtubules
1
2011
237
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
742
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
924
0.020
Why?
Blotting, Western
1
2010
1143
0.020
Why?
Polymerase Chain Reaction
1
2010
990
0.020
Why?
Cross-Sectional Studies
1
2018
4402
0.020
Why?
Cytokines
1
2014
1824
0.020
Why?
Chronic Disease
1
2012
1577
0.020
Why?
Leukemia, Myeloid, Acute
1
2012
533
0.020
Why?
Infant
1
2018
7943
0.020
Why?
Severity of Illness Index
1
2011
2537
0.010
Why?
Treatment Outcome
1
2016
9049
0.010
Why?
Signal Transduction
1
2011
4501
0.010
Why?
Post's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)